0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 Establishing target product profiles for Lassa fever diagnostics: A collaborative approach to guide innovation and public health investment [Conference Abstract] August 20, 2025 by Esther Butamanya
0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 Expanding clinical trial access through a mobile clinical trials unit to strengthen epidemic preparedness in rural and underserved communities in Nigeria [Conference Abstract] August 20, 2025 by Esther Butamanya
0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 Charting a course for Lassa fever vaccine development: Early lessons from Nigeria [Conference Abstract] August 20, 2025 by Esther Butamanya
0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 Assessment of challenges healthcare providers face when communicating delayed laboratory results to patients managed for Lassa fever in Benue State, Nigeria [Conference abstract] August 20, 2025 by Esther Butamanya
0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 Establishing an external quality assurance (EQA) system for Lassa fever testing in Nigeria [Conference Abstract] August 20, 2025 by Esther Butamanya
0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 Bioinformatics designing of an mRNA vaccine for Mokolavirus (MOKV) using immunoinformatics as a secure strategy for successful vaccine development [Conference Abstract] August 20, 2025 by Esther Butamanya
